TWI682777B - Use of tanaka bark extracts for reducing skin aging - Google Patents

Use of tanaka bark extracts for reducing skin aging Download PDF

Info

Publication number
TWI682777B
TWI682777B TW107127467A TW107127467A TWI682777B TW I682777 B TWI682777 B TW I682777B TW 107127467 A TW107127467 A TW 107127467A TW 107127467 A TW107127467 A TW 107127467A TW I682777 B TWI682777 B TW I682777B
Authority
TW
Taiwan
Prior art keywords
skin
bark
extract
cells
tenaka
Prior art date
Application number
TW107127467A
Other languages
Chinese (zh)
Other versions
TW202007410A (en
Inventor
林詠翔
Original Assignee
大江生醫股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大江生醫股份有限公司 filed Critical 大江生醫股份有限公司
Priority to TW107127467A priority Critical patent/TWI682777B/en
Priority to CN201910193115.XA priority patent/CN110812291A/en
Application granted granted Critical
Publication of TWI682777B publication Critical patent/TWI682777B/en
Publication of TW202007410A publication Critical patent/TW202007410A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Abstract

The present invention relates to applications of a Tanaka bark extract in manufacture of composition for reducing skin aging. The Tanaka bark extract is prepared by extracting Tanaka barks using water, alcohols, or mixtures of water and alcohols as solvents. This extract is effective in increasing resistance of skin cells to ultraviolet irradiation, reducing damage to nucleic acids in skin cells, improving skin texture, and reducing brown spots.

Description

特納卡樹皮萃取物用於預防皮膚老化之用途 Uses of Tenaka bark extract for preventing skin aging

本發明係關於一種植物萃取物的用途,特別係關於一種特納卡樹皮萃取物用於製備預防皮膚老化之組合物之用途。 The invention relates to the use of a plant extract, in particular to the use of a Tenka bark extract for preparing a composition for preventing skin aging.

皮膚提供個體對抗陽光中紫外線(ultraviolet,UV)輻射、病原體、摩擦力等環境因子的第一階段保護。皮膚由外向內依序包含表皮層、主要由結締組織構成的真皮層、及皮下組織。表皮層包含最外側的角質層並且不斷更新。表皮層與真皮層間存在持續分裂的細胞,例如皮膚纖維母細胞(skin fibroblasts)、角質細胞(keratinocytes)、及黑色素細胞(melanocytes)。真皮層含有膠原蛋白(collagen)、彈力蛋白(elastin)、及玻尿酸(hyaluronic acid)等分子,其賦予肌膚彈性和支撐力量。隨著年齡增長,皮膚會出現皺紋、細紋、鬆弛、凹陷、毛孔粗大、黑色素沉澱等老化現象。這些皮膚老化現象的形成與諸多因素有關,例如真皮層內的膠原蛋白、彈力蛋白、及玻尿酸等分子的含量隨年齡增加而減少,暴露於高量的紫外線(主要是紫外線A)會導致皮膚細胞死亡或核酸分子損傷。 The skin provides the first-stage protection of individuals against environmental factors such as ultraviolet (UV) radiation, pathogens, friction in sunlight. The skin sequentially includes the epidermal layer, the dermis layer mainly composed of connective tissue, and the subcutaneous tissue from outside to inside. The epidermis contains the outermost cuticle and is constantly updated. There are continuously dividing cells between the epidermis and the dermis, such as skin fibroblasts, keratinocytes, and melanocytes. The dermis layer contains collagen, elastin, and hyaluronic acid and other molecules, which give the skin elasticity and support. With age, the skin will show aging phenomena such as wrinkles, fine lines, sagging, depression, enlarged pores, and melanin precipitation. The formation of these skin aging phenomena is related to many factors. For example, the content of molecules such as collagen, elastin, and hyaluronic acid in the dermis layer decreases with age. Exposure to high amounts of ultraviolet light (mainly ultraviolet A) can cause skin cells Death or nucleic acid molecule damage.

市面上用以改善前述皮膚老化現象的方法包含直接注射膠原蛋白或玻尿酸至真皮層,以口服方式補充膠原蛋白或玻尿酸,及使用防曬品以減少紫外線所致皮膚傷害等。然而,注射至皮膚的膠原蛋白或玻尿酸易隨時間被體內酵素分解,導致必須定期施打該些物質,花費甚鉅。以口服方式補充膠原蛋白或玻尿酸會造成該些大分子在腸胃道中被消化為小分子的胺基酸或單醣,儘管身體能利用這些胺基酸或單醣合成蛋白質或多醣,但不必然形成膠原蛋白或玻尿酸,因此補充膠原蛋白或玻尿酸的實質效果有限。此外,防曬品含有的 化學物質可能引發光敏性,以致該些化學物質與紫外線的結合對皮膚產生不良影響,例如皮疹或更嚴重的曬傷。 Methods available on the market to improve the aforementioned skin aging phenomenon include direct injection of collagen or hyaluronic acid into the dermis layer, oral supplementation of collagen or hyaluronic acid, and use of sunscreen to reduce skin damage caused by ultraviolet rays. However, collagen or hyaluronic acid injected into the skin is easily broken down by enzymes in the body over time, which results in the need to regularly apply these substances, which is very expensive. Oral supplementation of collagen or hyaluronic acid will cause these large molecules to be digested into small molecules of amino acids or monosaccharides in the gastrointestinal tract. Although the body can use these amino acids or monosaccharides to synthesize proteins or polysaccharides, they are not necessarily formed Collagen or hyaluronic acid, so the substantial effect of supplementing collagen or hyaluronic acid is limited. In addition, the sunscreen contains Chemicals may cause photosensitivity, so that the combination of these chemicals and ultraviolet light has an adverse effect on the skin, such as a rash or more severe sunburn.

有鑑於此,開發一種成分天然、可直接施用於皮膚、又能有效減緩皮膚老化的組合物,以維持皮膚健康及降低皮膚病變的發生,實有其必要。 In view of this, it is necessary to develop a composition with natural ingredients that can be directly applied to the skin and can effectively slow down skin aging to maintain skin health and reduce the occurrence of skin lesions.

緣此,本發明之一目的在提供一種特納卡(Tanaka)樹皮萃取物用於製備預防皮膚老化之組合物之用途,其中該特納卡樹皮萃取物係以一溶劑萃取一特納卡樹皮而獲得。 Therefore, an object of the present invention is to provide a use of Tanaka bark extract for preparing a composition for preventing skin aging, wherein the Tenaka bark extract is a solvent to extract a Tenka bark And get.

在本發明之一實施例中,該溶劑為水、醇、或醇水混合物,該溶劑與該特納卡樹皮之重量比為20:1至1:1,且該萃取步驟係在50℃至80℃進行。 In one embodiment of the present invention, the solvent is water, alcohol, or an alcohol-water mixture, the weight ratio of the solvent to the tenacar bark is 20:1 to 1:1, and the extraction step is at 50°C to At 80°C.

在本發明之一實施例中,該特納卡樹皮萃取物係為一特納卡樹皮的水萃取物,其濃度為至少0.5mg/ml。 In one embodiment of the present invention, the Tenaka bark extract is a water extract of Tenaka bark, the concentration of which is at least 0.5 mg/ml.

在本發明之一實施例中,該特納卡樹皮萃取物提升一皮膚細胞對紫外線的抵抗力,減少一皮膚細胞中的一核酸分子的損傷,或改善皮膚紋理與減少斑點。 In one embodiment of the present invention, the Tenaka bark extract enhances the resistance of a skin cell to ultraviolet rays, reduces the damage of a nucleic acid molecule in a skin cell, or improves the skin texture and reduces spots.

在本發明之一實施例中,本發明組合物之形式為粉末狀、顆粒狀、液狀、膠狀或膏狀之劑型。 In one embodiment of the present invention, the composition of the present invention is in the form of powder, granule, liquid, gel or paste.

鑒於特納卡樹皮萃取物有效抑制促成皮膚老化的環境因子的作用,如紫外線誘導皮膚纖維母細胞死亡、核酸分子因氧化壓力而損傷,特納卡樹皮萃取成物可用於製備預防皮膚老化之組合物。 In view of the effects of Tenaka bark extract on effectively inhibiting environmental factors that contribute to skin aging, such as ultraviolet-induced skin fibroblast death and nucleic acid molecule damage due to oxidative stress, Tenka bark extract can be used to prepare a combination to prevent skin aging Thing.

以下將配合圖式進一步說明本發明的實施方式,下述所列舉的實施例係用以闡明本發明之發明特點及應用,而非以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 The following will further illustrate the embodiments of the present invention with reference to the drawings. The following examples are used to illustrate the inventive features and applications of the present invention, rather than to limit the scope of the present invention. Anyone who is familiar with this skill will not deviate from it. Within the spirit and scope of the present invention, some changes and modifications can be made, so the scope of protection of the present invention shall be deemed as defined by the scope of the attached patent application.

圖1顯示特納卡樹皮萃取物提升皮膚纖維母細胞對紫外線A(UVA)照射的抵抗力。 Figure 1 shows that Tenka bark extract enhances the resistance of skin fibroblasts to ultraviolet A (UVA) irradiation.

圖2顯示特納卡樹皮萃取物減少過氧化氫(H2O2)所致皮膚纖維母細胞內活性氧物質的累積。 Figure 2 shows that the extract of Tenaka bark reduces the accumulation of reactive oxygen species in skin fibroblasts caused by hydrogen peroxide (H 2 O 2 ).

圖3顯示特納卡樹皮萃取物減少過氧化氫(H2O2)所致皮膚纖維母細胞內核酸分子的損傷。 Figure 3 shows that the extract of Tenaka bark reduces the damage of nucleic acid molecules in skin fibroblasts caused by hydrogen peroxide (H 2 O 2 ).

圖4顯示連續四週施用含1%特納卡樹皮萃取物之精華液或安慰劑於受試者臉部皮膚後,其皮膚紋理的改善率。 Figure 4 shows the improvement rate of the skin texture after applying the essence or placebo containing 1% Tenaka bark extract to the skin of the subject's face for four consecutive weeks.

圖5顯示連續四週施用含1%特納卡樹皮萃取物之精華液或安慰劑於受試者臉部皮膚後,其皮膚上棕色斑點相對量的變化。 Figure 5 shows the change in the relative amount of brown spots on the skin of the subject's skin after applying the essence or placebo containing 1% Tenaka bark extract to the skin of the subject's face for four consecutive weeks.

定義definition

本文中所使用數值為近似值,所有實驗數據皆表示在20%的範圍內,較佳為在10%的範圍內,最佳為在5%的範圍內。 The numerical values used in this article are approximate values, and all experimental data are expressed within a range of 20%, preferably within a range of 10%, and most preferably within a range of 5%.

本發明提供一種特納卡樹皮萃取物用於製備預防皮膚老化之組合物之用途。以下實施例中揭露特納卡樹皮萃取物或包含該萃取物的組合物能減少紫外線照射所致皮膚纖維母細胞的死亡,減少皮膚細胞中核酸分子的損傷,及改善皮膚紋理與減少斑點。 The invention provides a use of Tenaka bark extract for preparing a composition for preventing skin aging. In the following examples, it is disclosed that the Tenaka bark extract or the composition containing the extract can reduce the death of skin fibroblasts caused by ultraviolet radiation, reduce the damage of nucleic acid molecules in skin cells, and improve skin texture and reduce spots.

材料與方法Materials and Methods 材料material

自Thermo Fisher Scientific公司購買含Earle’s平衡鹽溶液之Eagle’s最低基本培養基(Eagle’s minimum essential medium,簡稱MEM培養基),胎牛血清(fetal bovine serum,FBS),非必需胺基酸,碳酸氫鈉,丙酮酸鈉,及磷酸緩衝鹽溶液(phosphate buffered saline,PBS)。自Amersco公司購買用於細胞存活分析之3-(4,5-二甲基-2-噻唑基)-2,5-二苯基四氮唑溴化物(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide,MTT)。自ECHO Chemical公司購買二甲基亞碸(dimethyl sulfoxide,DMSO)。自Sigma公司購買過氧化氫及二氯二氫螢光 素二乙酸酯(2,7-dichloro-dihydro-fluorescein diacetate,DCFH-DA)。該DCFH-DA使用前係溶於DMSO以配製為5mg/ml DCFH-DA溶液。 Purchase Eagle's minimum essential medium (MEM medium), Fetal bovine serum (FBS), non-essential amino acids, sodium bicarbonate, pyruvate from Thermo Fisher Scientific Sodium, and phosphate buffered saline (PBS). Purchase 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (3-(4,5-dimethylthiazol-2 -yl)-2,5-diphenyltetrazolium bromide (MTT). Purchase dimethyl sulfoxide (DMSO) from ECHO Chemical. Purchase hydrogen peroxide and dichlorodihydrofluorescence from Sigma Diacetate (2,7-dichloro-dihydro-fluorescein diacetate, DCFH-DA). The DCFH-DA is dissolved in DMSO before use to prepare a 5 mg/ml DCFH-DA solution.

細胞培養Cell culture

以下實施例使用購自食品工業研究所生物資源保存及研究中心(Bioresource Collection and Research Center,BCRC)的人類皮膚纖維母細胞CCD-966SK(BCRC 60153)進行體外實驗。人類皮膚纖維母細胞在37℃、5%二氧化碳的條件下培養於添加10% FBS、0.1mM非必需胺基酸、1.5g/L碳酸氫鈉、1mM丙酮酸鈉之MEM培養基,以下稱細胞培養基。 The following examples used human skin fibroblast CCD-966SK (BCRC 60153) purchased from the Bioresource Collection and Research Center (BCRC) of the Food Industry Research Institute for in vitro experiments. Human skin fibroblasts are cultured in MEM medium supplemented with 10% FBS, 0.1 mM non-essential amino acids, 1.5 g/L sodium bicarbonate, and 1 mM sodium pyruvate at 37°C and 5% carbon dioxide, hereinafter referred to as cell culture medium .

MTT分析MTT analysis

細胞存活率係以MTT分析測定。簡言之,將MTT溶液(4mg/ml MTT溶於PBS溶液)依15μl/孔添加至96孔盤中的細胞,於37℃反應4小時。移除反應液後,將DMSO依50μl/孔添加至細胞並震盪反應10分鐘以溶解所生成的甲

Figure 107127467-A0101-12-0004-6
(formazan)結晶。最終,使用ELISA讀盤機(enzyme-linked immunosorbent assay reader;BioTek)測量該細胞混合物在570nm的吸光值(O.D.570)。 Cell survival rate was determined by MTT analysis. Briefly, MTT solution (4 mg/ml MTT dissolved in PBS solution) was added to cells in a 96-well dish at 15 μl/well, and reacted at 37° C. for 4 hours. After removing the reaction solution, add 50 μl/well of DMSO to the cells and shake the reaction for 10 minutes to dissolve the generated formazan.
Figure 107127467-A0101-12-0004-6
(formazan) crystallization. Finally, the absorbance at 570 nm (OD570) of the cell mixture was measured using an ELISA disk reader (Enzyme-linked immunosorbent assay reader; BioTek).

統計分析Statistical Analysis

各實驗資料之統計上顯著差異係以Excel軟體之學生t檢定判定。 The statistically significant differences in the experimental data are determined by the Student t test of Excel software.

實施例1Example 1 特納卡樹皮萃取物之製備Preparation of Tenaka Bark Extract

本實施例舉例說明特納卡樹皮萃取物之製備方法。首先,將特納卡樹皮(Tanaka,又名Limonia acidissima)洗淨及乾燥,以切割、研磨或其它類似方式使該樹皮粗碎成片狀、粒狀、或粉狀。其次,以水物為溶劑對該片狀、粒狀、或粉狀之特納卡樹皮進行萃取,該溶劑與該特納卡樹皮之重量比為20:1至1:1,萃取溫度為介於50℃至80℃,較佳為60℃至70℃。萃取時間約為0.5至3小時。經該萃取步驟所得特納卡樹皮萃取物冷卻至室溫後,經由400目(mesh)之濾網過濾以移除殘餘固體物。該過濾後的特納卡樹皮萃取物可進一步在45℃至70℃進行減壓濃縮而獲得一濃縮產物。為獲得固態的特納卡樹皮萃取物,可將前述經減壓濃縮的特納卡樹皮萃取物以噴霧乾燥方式去除溶劑,因此獲得特納卡樹皮萃取物粉末。 This example illustrates the preparation method of the extract of Tenacar bark. First, the Tenaka bark (Tanaka, also known as Limonia acidissima ) is washed and dried, and the bark is coarsely crushed into flakes, granules, or powder by cutting, grinding, or other similar methods. Secondly, the flake, granular, or powdered Tenaka bark is extracted with water as the solvent, the weight ratio of the solvent to the Tenaka bark is 20:1 to 1:1, and the extraction temperature is between At 50°C to 80°C, preferably 60°C to 70°C. The extraction time is about 0.5 to 3 hours. After the extract of the Tenaka bark obtained through this extraction step was cooled to room temperature, it was filtered through a 400 mesh filter to remove residual solids. The filtered Tenaka bark extract can be further concentrated under reduced pressure at 45°C to 70°C to obtain a concentrated product. In order to obtain the solid Tenaka bark extract, the aforementioned reduced-pressure concentrated Tenaka bark extract may be spray-dried to remove the solvent, thus obtaining Tenka bark extract powder.

實施例2Example 2 特納卡樹皮萃取物抑制紫外線照射所致皮膚纖維母細胞死亡Tenaka bark extract inhibits skin fibroblast death caused by ultraviolet radiation

為檢驗特納卡樹皮萃取物保護皮膚對抗紫外線照射的效果,利用細胞存活分析(MTT分析)評估經過紫外線A照射的人類皮膚纖維母細胞CCD-966SK在特納卡樹皮萃取物處理後的細胞存活率。簡言之,將5×103個CCD-966SK細胞接種於含有200μL細胞培養基之96孔盤的各孔,在37℃下培養24小時後,移除細胞培養基,並添加含有1mg/mL特納卡樹皮水萃取物之細胞培養基至細胞以作為實驗組,其於37℃下再培養24小時。其後,將該細胞置於紫外線照射箱(Vilber)中以接受12J/cm2紫外線A(波長315-400mn)照射1小時,此輻射劑量會造成半數細胞死亡。為供比較,另設置一組經前述劑量紫外線A照射但以不含特納卡樹皮水萃取物之細胞培養基處理的細胞以作為負控制組,及設置一組未予紫外線A照射且僅以不含特納卡樹皮水萃取物之細胞培養基處理的細胞以作為空白對照組。最終,進行MTT分析及依下列公式計算各組細胞(四重複實驗)之細胞存活率:細胞存活率=各組的O.D.570/空白對照組的O.D.570×100% To test the effect of Tenaka bark extract on protecting the skin against ultraviolet radiation, cell survival analysis (MTT analysis) was used to evaluate the cell survival of human skin fibroblast CCD-966SK after ultraviolet A irradiation after Tenka bark extract treatment rate. Briefly, 5×10 3 CCD-966SK cells were seeded into each well of a 96-well dish containing 200 μL of cell culture medium, and after culturing at 37° C. for 24 hours, the cell culture medium was removed, and a solution containing 1 mg/mL Turner was added. Cell culture medium of card bark water extract was used as the experimental group, which was incubated at 37°C for another 24 hours. After that, the cells were placed in an ultraviolet irradiation box (Vilber) to receive 12J/cm 2 ultraviolet A (wavelength 315-400mn) for 1 hour. This radiation dose caused half of the cells to die. For comparison, a group of cells irradiated with the aforementioned dose of ultraviolet A but treated with a cell culture medium that does not contain the water extract of Tenacar bark was used as a negative control group, and a group of cells that were not irradiated with ultraviolet A and only Cells treated with cell culture medium containing water extracts of Tenaka bark were used as blank control group. Finally, perform MTT analysis and calculate the cell survival rate of each group of cells (quadruple experiment) according to the following formula: cell survival rate = OD570 of each group/OD570×100% of blank control group

圖1顯示CCD-966SK細胞在前述不同處理後的細胞存活率;圖中*及***分別表示相對於負控制組之p<0.05及p<0.001。依據圖1,負控制組相比空白對照組有顯著降低的細胞存活率,顯示紫外線A照射會造成皮膚纖維母細胞大量死亡。然而,相比負控制組,特納卡樹皮水萃取物之處理卻使實驗組細胞的存活率明顯上升16.7%,說明特納卡樹皮萃取物能提升皮膚細胞對紫外線的抵抗力。 Figure 1 shows the cell survival rate of CCD-966SK cells after the aforementioned different treatments; * and *** in the figure represent p <0.05 and p <0.001, respectively, relative to the negative control group. According to Figure 1, the negative control group had a significantly reduced cell survival rate compared to the blank control group, showing that ultraviolet A irradiation would cause a large number of skin fibroblast death. However, compared with the negative control group, the treatment of Tenaka bark water extract increased the survival rate of cells in the experimental group by 16.7%, indicating that Tenka bark extract can increase the resistance of skin cells to ultraviolet rays.

實施例3Example 3 特納卡樹皮萃取物減少皮膚纖維母細胞中的活性氧物質之累積Tenaka bark extract reduces the accumulation of reactive oxygen species in skin fibroblasts

為探討特納卡樹皮萃取物對皮膚細胞中氧化壓力的調節作用,利用螢光探針DCFH-DA配合流式細胞儀(flow cytometry;Beckman),測定人類皮膚纖維母細胞CCD-966SK經特納卡樹皮萃取物處理後,其在氧化刺激下的活性氧物質(reactive oxygen species,ROS)含量變化。簡言之,將2×105個CCD-966SK細胞接種於含有2ml細胞培養基之6孔培養盤的各孔,在37℃下培養24小時後, 移除該培養基。其後,該細胞在37℃下依序以2mL含有0.5或1mg/mL特納卡樹皮水萃取物之細胞培養基處理1小時,以5μg/ml DCFH-DA溶液處理細胞15分鐘,再以1mM過氧化氫處理1小時。使用PBS溶液清洗該細胞二次後,於暗處以200μl胰蛋白酶處理細胞5分鐘,再收集細胞與培養基以離心方式(400xg,10分鐘)移除上清液。由此所得細胞沉澱物以PBS溶液清洗一次及再次懸浮,並使用流式細胞儀偵測細胞的螢光強度。進行螢光偵測之激發波長為450-490nm,放射波長為510-550nm。由於DCFH-DA進入細胞後會先被水解為DCFH(二氯二氫螢光素),再被活性氧物質氧化為可發出綠色螢光的DCF(二氯螢光素),經DCFH-DA處理之細胞的螢光強度可反映細胞內活性氧物質含量。為供比較,另設置一組先後經過氧化氫及不含特納卡樹皮水萃取物之細胞培養基處理的細胞以作為負控制組,及設置一組未予過氧化氫而僅以不含特納卡樹皮水萃取物之細胞培養基處理的細胞以作為空白對照組。 To investigate the regulatory effect of Tenaka bark extract on oxidative stress in skin cells, fluorescent probe DCFH-DA was used in conjunction with flow cytometry (Beckman) to determine human skin fibroblast CCD-966SK via Turner After the card bark extract treatment, the content of reactive oxygen species (ROS) under oxidative stimulation changes. Briefly, 2×10 5 CCD-966SK cells were seeded into each well of a 6-well culture dish containing 2 ml of cell culture medium, and after culturing at 37° C. for 24 hours, the medium was removed. Thereafter, the cells were sequentially treated with 2 mL of cell culture medium containing 0.5 or 1 mg/mL Tenaka bark water extract at 37°C for 1 hour, cells were treated with 5 μg/ml DCFH-DA solution for 15 minutes, and then treated with 1 mM Hydrogen oxide treatment for 1 hour. After washing the cells twice with PBS solution, the cells were treated with 200 μl trypsin in the dark for 5 minutes, and then the cells and the medium were collected and the supernatant was removed by centrifugation (400×g, 10 minutes). The cell pellet thus obtained was washed once with PBS solution and suspended again, and the fluorescence intensity of the cells was detected using a flow cytometer. The excitation wavelength for fluorescence detection is 450-490nm, and the emission wavelength is 510-550nm. Since DCFH-DA enters the cell, it will be hydrolyzed to DCFH (dichlorodihydrofluorescein), and then oxidized by reactive oxygen species to DCF (dichlorofluorescein), which can emit green fluorescence, and then treated by DCFH-DA The fluorescence intensity of the cells can reflect the content of reactive oxygen species in the cells. For comparison, another set of cells that have been treated with hydrogen oxide and cell culture medium without Tenka bark water extract as a negative control group, and one set without hydrogen peroxide but only without Turner Cells treated with cell culture medium of card bark water extract were used as blank control group.

圖2顯示CCD-966SK細胞在前述不同處理後的活性氧物質相對含量(%),以負控制組細胞的活性氧物質含量界定為100%;圖中***表示相對於負控制組之p<0.001。依據圖2,負控制組相比空白對照組呈現明顯較高的活性氧物質含量,顯示過氧化氫處理會導致細胞內活性氧物質之累積。然而,相比負控制組,0.5或1mg/mL特納卡樹皮水萃取物之處理使細胞內活性氧物質降低約60%,顯示特納卡樹皮水萃取物具有清除活性氧物質的能力。 Figure 2 shows the relative content (%) of active oxygen species of CCD-966SK cells after the different treatments described above, defined as the active oxygen species content of cells in the negative control group as 100%; *** in the figure represents p relative to the negative control group <0.001. According to Fig. 2, the negative control group showed a significantly higher content of reactive oxygen species than the blank control group, showing that hydrogen peroxide treatment would result in the accumulation of reactive oxygen species in the cells. However, compared with the negative control group, the treatment of 0.5 or 1 mg/mL Tenka bark water extract reduced the intracellular active oxygen species by approximately 60%, showing that Tenka bark water extract has the ability to scavenge active oxygen species.

實施例4Example 4 特納卡樹皮萃取物減少細胞內核酸分子的損傷Tenaka bark extract reduces intracellular nucleic acid molecule damage

為檢驗特納卡樹皮萃取物對皮膚細胞內核酸分子的保護作用,依類似實施例3所述方法處理人類皮膚纖維母細胞CCD-966SK,並利用單細胞膠體電泳(single cell gel electrophoresis,SCGE)分析細胞經過不同處理後的染色體核酸分子的受損情況。簡言之,設置三組CCD-966SK細胞,第一組細胞先以1mM過氧化氫處理1小時,再以含有0.5或1mg/mL特納卡樹皮水萃取物之細胞培養基處理1小時;第二組細胞先後給予氧化氫及不含特納卡樹皮水萃取物之細胞培養基(負控制組);第三組細胞未予過氧化氫而僅以不含特納卡樹皮水萃取物之細胞培養基處理(空白對照組)。其後,收集該三組細胞以進行單細胞膠體電泳,並測 量染色膠體中的核酸分子拖尾長度。由於斷裂的核酸分子會在細胞電泳後呈現拖尾現象,該拖尾的長度可用於定量核酸分子的損傷程度。 To test the protective effect of Tenka bark extract on nucleic acid molecules in skin cells, human skin fibroblast CCD-966SK was treated in a similar manner as described in Example 3, and single cell gel electrophoresis (SCGE) was used Analyze the damage of chromosomal nucleic acid molecules after different treatments. Briefly, three groups of CCD-966SK cells were set up. The first group of cells was first treated with 1 mM hydrogen peroxide for 1 hour, and then treated with cell culture medium containing 0.5 or 1 mg/mL Tenaka bark water extract for 1 hour; second The cells in the group were treated with hydrogen oxide and cell culture medium without the extract of Tenacar bark (negative control group); the cells in the third group were treated with cell culture medium without the extract of Tenacar bark without the use of hydrogen peroxide. (Blank control group). Afterwards, the three groups of cells were collected for single-cell colloid electrophoresis and measured The length of the tail of the nucleic acid molecule in the stained colloid. Since the broken nucleic acid molecule will show a tailing phenomenon after cell electrophoresis, the length of the tailing can be used to quantify the degree of damage of the nucleic acid molecule.

圖3顯示上述各組CCD-966SK細胞於電泳後的核酸拖尾相對長度(%),以空白對照組的核酸分子拖尾長度界定為100%;圖中***表示相對於空白對照組之p<0.001,###表示相對於負控制組之p<0.001。依據圖3,負控制組相比空白對照組有明顯較長的核酸拖尾,顯示過氧化氫處理會嚴重損傷細胞的核酸分子。然而,相比負控制組,0.5或1mg/mL特納卡樹皮水萃取物之處理使該核酸拖尾縮短約62.5%,說明特納卡樹皮萃取物能減少皮膚細胞中核酸分子的損傷。 Figure 3 shows the relative length (%) of nucleic acid tailing of each group of CCD-966SK cells after electrophoresis in the above groups. The length of nucleic acid molecule tailing of the blank control group is defined as 100%; *** in the figure represents the relative length of the blank control group p <0.001, ### represents a negative control group with respect to the p <0.001. According to Figure 3, the negative control group had significantly longer nucleic acid tails than the blank control group, showing that hydrogen peroxide treatment would seriously damage the nucleic acid molecules of the cells. However, compared with the negative control group, treatment with 0.5 or 1 mg/mL Tenka bark water extract shortened the nucleic acid tail by approximately 62.5%, indicating that Tenka bark extract can reduce the damage of nucleic acid molecules in skin cells.

實施例5Example 5 特納卡樹皮萃取物改善皮膚紋理及減少斑點Tenaka bark extract improves skin texture and reduces spots

特納卡樹皮萃取物可製備供局部施用於皮膚之組合物,其可具有但不限於溶液、乳液、乳霜或凝膠之型態。在一實施例中,該組合物為含有1% w/w特納卡樹皮水萃取物之精華液(含一基底溶劑,其成分包括水、馨鮮酮、己二醇、1,3-丁二醇、三仙膠、增稠劑、及三乙醇胺)。為評估此組合物對皮膚狀態的影響,將該精華液與作為安慰劑之該基底溶劑於每日早晚各一次分別塗抹於9位25至40歲之包含男性及女性受試者已清潔過的左、右半臉,並於使用前及連續使用四週後以全臉膚質檢測儀(7th Generation VISIA Complexion Analysis System;Canfield,USA)測定該些受試者的全臉皮膚紋理及棕色斑點數量。 Tenaka bark extract can be prepared for topical application to the skin, which can be in the form of, but not limited to, solution, lotion, cream or gel. In one embodiment, the composition is an essence containing 1% w/w Tenaka bark water extract (containing a base solvent, the ingredients of which include water, xanthanone, hexanediol, 1,3-butane Diol, three xanthan gum, thickener, and triethanolamine). To assess the effect of this composition on the skin condition, the essence and the base solvent as a placebo were applied to 9 cleaned and cleaned male and female subjects aged 25 to 40 years old, one time each day The left and right half faces were measured before and after four weeks of continuous use with a full-face skin quality tester (7th Generation VISIA Complexion Analysis System; Canfield, USA) to determine the full-face skin texture and the number of brown spots on these subjects.

圖4顯示前述受試者的皮膚紋理改善率(%)之平均值;界定施用前受試者的皮膚粗糙度為100%,以同一受試者於施用前後的皮膚粗糙度降低量作為皮膚紋理的改善率。依據圖4,相比安慰劑對皮膚紋理的改善約為10.5%,連續四週施用含特納卡樹皮水萃取物之精華液顯著改善皮膚紋理達17.4%。 Fig. 4 shows the average value of the skin texture improvement rate (%) of the aforementioned subjects; the skin roughness of the subject before application is defined as 100%, and the reduction in skin roughness of the same subject before and after application is taken as the skin texture Improvement rate. According to Figure 4, the improvement in skin texture compared to placebo is about 10.5%, and the application of essence containing Tenaka bark water extract for four consecutive weeks significantly improves skin texture by 17.4%.

圖5顯示前述受試者的棕色斑點相對量(%)之平均值,以施用前受試者皮膚的棕色斑點數量為100%。依據圖5,使用安慰劑無法減少皮膚的棕色斑點,但連續四週施用含特納卡樹皮水萃取物之精華液使棕色斑點減少7.7%。此結果證實特納卡樹皮萃取物減緩皮膚老化的效果。 Fig. 5 shows the average value of the relative amount (%) of brown spots of the aforementioned subject, with the number of brown spots of the subject's skin before application being 100%. According to Figure 5, the use of a placebo did not reduce the brown spots on the skin, but applying the essence containing Tenaka bark water extract for four consecutive weeks reduced the brown spots by 7.7%. This result confirms the effect of Tenaka bark extract to slow down skin aging.

綜上所述,特納卡樹皮萃取物或含有該萃取物的組合物能提升皮膚細胞對紫外線的抵抗力,減少皮膚細胞中核酸分子的損傷,及改善皮膚紋理與減少斑點,最終達到預防皮膚老化的目標。因此,特納卡樹皮萃取成物可用於製備預防皮膚老化之組合物。 In summary, Tenka bark extract or a composition containing the extract can enhance the resistance of skin cells to ultraviolet light, reduce the damage of nucleic acid molecules in skin cells, improve skin texture and reduce spots, and ultimately prevent skin Aging goals. Therefore, Tenka bark extract can be used to prepare a composition for preventing skin aging.

Claims (5)

一種特納卡樹皮萃取物用於製備改善皮膚紋理之組合物之用途,其中該特納卡樹皮萃取物係以水萃取一特納卡樹皮而獲得。 A use of Tenka bark extract for preparing a composition for improving skin texture, wherein the Tenka bark extract is obtained by extracting one Tenka bark with water. 如申請專利範圍第1項所述之用途,其中該水與該特納卡樹皮之重量比為20:1至1:1。 The use as described in item 1 of the patent application scope, wherein the weight ratio of the water to the tenacar bark is 20:1 to 1:1. 如申請專利範圍第1項所述之用途,其中該水萃取係在50℃至80℃進行。 The use as described in item 1 of the patent application scope, wherein the water extraction is carried out at 50 to 80°C. 如申請專利範圍第1項所述之用途,其中該特納卡樹皮萃取物的濃度為至少0.5mg/ml。 The use as described in item 1 of the patent application scope, wherein the concentration of the extract of Tenacar bark is at least 0.5 mg/ml. 如申請專利範圍第1項所述之用途,其中該組合物之形式為粉末狀、顆粒狀、液狀、膠狀或膏狀之劑型。 The use as described in item 1 of the scope of the patent application, wherein the composition is in the form of powder, granule, liquid, gel or paste.
TW107127467A 2018-08-07 2018-08-07 Use of tanaka bark extracts for reducing skin aging TWI682777B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW107127467A TWI682777B (en) 2018-08-07 2018-08-07 Use of tanaka bark extracts for reducing skin aging
CN201910193115.XA CN110812291A (en) 2018-08-07 2019-03-14 Use of extract of Ternacard bark for preventing skin aging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW107127467A TWI682777B (en) 2018-08-07 2018-08-07 Use of tanaka bark extracts for reducing skin aging

Publications (2)

Publication Number Publication Date
TWI682777B true TWI682777B (en) 2020-01-21
TW202007410A TW202007410A (en) 2020-02-16

Family

ID=69547565

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107127467A TWI682777B (en) 2018-08-07 2018-08-07 Use of tanaka bark extracts for reducing skin aging

Country Status (2)

Country Link
CN (1) CN110812291A (en)
TW (1) TWI682777B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107669557A (en) * 2017-11-08 2018-02-09 广州市络捷生物科技有限公司 A kind of Ta Naka extracting methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5865209A (en) * 1981-10-14 1983-04-18 Shiseido Co Ltd Cosmetic
KR20090087223A (en) * 2008-02-12 2009-08-17 주식회사 코리아나화장품 Cosmetic composition for pore-minimizing containing limonia acidissima extract
JP5534654B2 (en) * 2008-06-11 2014-07-02 丸善製薬株式会社 Anti-inflammatory agent
CN103800239B (en) * 2014-02-18 2016-06-08 广州中医药大学科技产业园有限公司 A kind of ultra light sun block lotion and preparation method thereof
CN108815036A (en) * 2018-07-29 2018-11-16 佛山市芊茹化妆品有限公司 A kind of preparation method and applications of Ta Naka extract

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107669557A (en) * 2017-11-08 2018-02-09 广州市络捷生物科技有限公司 A kind of Ta Naka extracting methods

Also Published As

Publication number Publication date
CN110812291A (en) 2020-02-21
TW202007410A (en) 2020-02-16

Similar Documents

Publication Publication Date Title
US20060134059A1 (en) Compositions and methods of their use for improving the condition and appearance of skin
KR101035858B1 (en) Sargassum sp. extract that have low photo-induced cytotoxicity, preparation method thereof and cosmetic composition containing the same
CN107049894A (en) A kind of daily repairing type Essence and preparation method thereof
Yoo et al. Effects of egg shell membrane hydrolysates on UVB-radiation-induced wrinkle formation in SKH-1 hairless mice
US20160184217A1 (en) Preparation for protection against extrinsic and intrinsic skin aging
EP3566751A1 (en) Cosmetic compositions containing cloudberry cell culture preparation
JP6049119B2 (en) Ran Vanda Cerulea as a cosmetic active agent
US9084744B1 (en) Use of Tiliacora triandra in cosmetics and compositions thereof
KR101129239B1 (en) Cosemtics composition containing the extract of allithiamine fermented
EP2763652B1 (en) Use of glucans obtained from prunus persica as an anti-aging cosmetic agent
CN107802576A (en) A kind of natural animal-plant cell replenishers and preparation method thereof
KR101727788B1 (en) Sargassum thunbergii hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same
TWI682777B (en) Use of tanaka bark extracts for reducing skin aging
KR101585913B1 (en) Method for production of horse leg bone extract and cosmetic composition with the extract of horse leg bone
KR20210055475A (en) A composition for improving skin beauty containing glycosaminoglycan
KR100882744B1 (en) Manufacturing method of cometic compositions containing extract of paeonia suffruticosa andrew
KR102011654B1 (en) Cosmetic composition comprising oysters, sea cucumber, sea squirt, Aplysia kurodai and buccinum striatissimum
JP5312733B2 (en) Moisturizer, cell activator, antioxidant, protease activity promoter, anti-aging agent, whitening agent, anti-inflammatory agent, neutral fat accumulation inhibitor
EP2519223A1 (en) An agent for stimulating the expression of loxl
FR2928549A1 (en) USE OF AN EXTRACT OF BRASSOCATTLEYA MARCELLA KOSS ORCHIDEE AS AN AGENT TO PREVENT OR DELAY THE APPEARANCE OF SIGNS OF SKIN AGING
TW201813629A (en) Hydrolysate of water extract of Syzygium samarangense, and the preparation process and uses thereof
KR101656710B1 (en) Extraction method of active material enhanced panax ginseng flower complex, and Anti-aging cosmetic composition prepared by the same
JP2002029923A (en) Collagen production promoter, elastase activity inhibitor, collagen activity inhibitor and skin cosmetic
KR20140083246A (en) Cosmetic composition comprising chungtaegeon
KR102139471B1 (en) Fermented composition of ice plant and collagen for anti-aging and anti-wrinkle, method for preparing the same and cosmetic composition comprising the same